CDT Equity Inc. (CDT): Total Liabilities
$12.82M
As of 2025-12-31
$23.61M
As of 2026-06-30
+8.3%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.82M | +16.7% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $10.99M | +43.0% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $7.68M | -23.9% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $10.09M | n/m | 2024-04-16, Balance as of period end |
| 2021-12-31 | $192.5K | n/a | 2023-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 2025-12-31 | $12.82M | +16.7% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $60.59M | +91.1% |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | $3.43M | -3.8% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $605.0K | +109.3% |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | $5.82M | n/a |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $2.29M | -87.3% |
Compare CDT, JUNS, AEON, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗